Penta acquires Lloyds pharmacies and a pharmaceutical distributor in the Czech Republic

14. August 2012
Back

Penta Investments, the Central European investment group, has agreed with Celesio AG to acquire its Lloyds pharmacy chain and Gehe wholesale distributor. The purchase price reached EUR 84.5 million.

Lloyds operates 55 pharmacies and is the third largest pharmacy chain in the Czech Republic, while Gehe is the fourth biggest wholesale pharmaceutical distributor in the Czech Republic. The transaction is subject to the Czech antitrust authority clearance.

The Lloyds pharmacies will be integrated into Ceska lekarna, a.s, which operates the Dr. Max pharmacy chain on the Czech market.

“We are consolidating pharmacies in Central Europe through Dr. Max and its local platforms. The Lloyds pharmacies and an important distributor Gehe have therefore been a very reasonable target for us. We strongly believe that market consolidation in the pharmacy sector significantly contributes to better quality and accessibility of services for patients,” said Václav Jirků, Investment Director at Penta.

“The integration of Lloyds pharmacies will support our efforts to become the most accessible pharmacy chain in terms of price and location, while the Gehe acquisition is an opportunity to implement our successful Dr. Max business model to the wholesale market. We plan to attract Gehe’s independent clients with strategies similar to those we used in the retail market, namely competitive price and services,” said Pavel Vajskebr, Dr. Max’s CEO.

 

About Lloyds

Lekarny Lloyds s.r.o. was established in 1993 and acquired by the current owner (the Celesio Group) in 2000.

Third biggest pharmacy chain in the Czech Republic, operating 55 pharmacies with a total turnover of EUR 55.7 million.

A diversified pharmacy portfolio, with most of the locations in shopping centres, communities and policlinics.

About Gehe

GEHE Pharma Praha, spol. s r.o. is the fourth largest pharmaceutical wholesaler in the Czech Republic, with a 17% market share and a revenue of EUR 420 million.

About Dr. Max

Dr. Max is one of the biggest pharmacy chains in Central Europe. It is a market leader in the Czech Republic (20% market share) and Slovakia (15%) and one of the biggest chains in Poland.

  • Over 450 pharmacies in the chain
  • Over 80,000 customers served daily
  • Over 2,000 employees
More news
Petr Řehák Appointed as the New CEO and Chairman of the Board of Privatbanka

Privatbanka, a.s., a member of the Penta Investments group, has appointed Petr Řehák as Chief Executive Officer and Chairman of the Board of Directors. He replaces Ľuboš Ševčík, who is...

Penta Fund strengthens its top management

Penta is strengthening the leadership of Penta Fund. After an exceptionally successful start, experienced banker Tomáš Hochmeister will become the new CEO of Penta Fund as of December 1. He...

Fortuna Entertainment Group Acquires Montenegrin Lob

Fortuna Entertainment Group (FEG), the leading omni-channel gaming entertainment provider in Central and Eastern Europe, has signed an agreement to acquire a 51% stake in Lob, Montenegro’s second biggest operator...

Penta Hospitals plans to acquire Group Mediterra and significantly expands its healthcare network, adding six hospitals and a medical school to the network

Prague, 16 October 2025 – Penta Hospitals, one of the leading private healthcare and social care providers in Czechia, has announced the signing for the acquisition of Group Mediterra, a.s....

Penta Real Estate successfully completed the sale of Bory Mall; its new owner is the ZFP Real Estate Fund

With the successful completion of the sale of the Bory Mall shopping and entertainment center, we have reached another important milestone in our activities on the Slovak market. The transaction...

Record year for Penta, successful launch of Penta Fund

Penta has reported a record net profit of €621 million for the financial year 2024. All core portfolio companies contributed to this results, as the high level of capital investments...

Fortuna leadership update – welcoming new CEO
Jaroslav Haščák returns to Penta’s top management

Jaroslav Haščák, the co-founder of the Penta investment group, returns to the top management of the company after almost four years. With effect from 1 October 2024, he will once...